Lv71
4946 积分 2021-05-26 加入
Discovery of BAY 2413555, First Selective Positive Allosteric Modulator of the M2 Receptor to Restore Cardiac Autonomic Balance
27天前
已完结
Clinical Translation of Targeted Protein Degraders
1个月前
已完结
Industry perspective on the nonclinical safety assessment of heterobifunctional degraders
1个月前
已完结
An overview of CDE technical guideline for nonclinical study of ADCS: importance and strategy of studying release of payload-containing components from ADC and their further metabolism
1个月前
已完结
Interspecies differences in gastrointestinal physiology affecting the in vivo performance of oral pharmaceutical solid dosage forms
2个月前
已完结
Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy
2个月前
已完结
Discovery of Novel 5,6-Dihydro-1,2,4-triazine Derivatives as Efficacious Glucagon-Like Peptide-1 Receptor Agonists
2个月前
已完结
Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9
2个月前
已完结
Radioactive ADME Demonstrates ARV-110’s High Druggability Despite Low Oral Bioavailability
3个月前
已完结
Development of a Series of Pyrrolopyridone MAT2A Inhibitors
3个月前
已完结
皖公网安备34019202002308
